Aman Khera

Looking at the road ahead to properly utilizing digital technology in clinical trials.

Roadmap of twists and turns that lie ahead following most recent draft issued in September.

The COVID-19 pandemic has pushed several focus areas to the forefront of the industry.

Findings from the most recent Biopharma Confidence Index show that the pandemic has substantially influenced biopharma executives’ expectations in key areas like artificial intelligence/machine learning and real-world evidence.